ID Grand Rounds. August 26, 2014

Case # 1. A 65 year old, CMV D+/R- kidney transplant recipient receiving mycophenolate and prednisone presented with 1 month h/o hematuria and progressive renal failure secondary to adenovirus nephritis.

From: https://www.google.com/search?q=adenovirus+electron+microscopy&source=lnms&tbm=isch&sa=X&ei=RP_8U9GlGsO0yAS5lICQCQ&ved=0CAgQ_AUoAQ&biw=1920&bih=943#facrc=_&imgdii=_&imgrc=jysh9OgcvqH5YM%253A%3BqFxYXFIK5hJFGM%3Bhttp%253A%252F%252Fwww.virology.net%252Fbig_virology%252FEM%252FAdeno-FD.jpg%3Bhttp%253A%252F%252Fwww.virology.net%252Fbig_virology%252FBVDNAadeno.html%3B979%3B964

1. Know the different clinical manifestations of adenovirus infection in immunocompromised patients: pneumonia (including necrotizing pneumonia and diffuse alveolar damage), gastroenteritis, hepatitis, hemorrhagic cystitis, interstitial nephritis, and meningoencephalitis. Among immunocompetent patients, adenovirus infection usually manifests as nonspecific upper respiratory tract illness, gastroenteritis, pharyngo-conjunctival fever, and epidemic keratoconjunctivitis.

2. Kidney transplant recipients who developed adenovirus graft-nephritis had better survival compared to other transplant recipients who developed native-kidney adenovirus nephritis according to one case series.

3. Histopathologic examination of a biopsy specimen is the gold standard for diagnosing invasive adenoviral infection. In situ hybridization is utilized to confirm the presence of the virus in tissues. Cells infected with adenovirus have large nuclei with basophilic inclusions and a thin rim of cytoplasm (so called smudge cells). Granulomatous formation is often observed. Adenovirus PCR can also be used but it should always be correlated with histopathology and with the clinical presentation to distinguish between asymptomatic infection and disease.

4. In immunosuppressed patients, the cornerstone of management for invasive adenovirus infection is supportive care and reduction of immunosuppression (read here). If treatment is desired, cidofovir is likely the best antiviral agent to use. Probenecid is used together with cidofovir to block active renal tubular secretion of cidofovir, thereby, preventing the development of nephrotoxicity. Aggressive hydration with fluid is recommended with cidofovir use.

5. In patients who develop adenovirus nephritis, concurrent use of probenecid is not recommended to ensure increased drug delivery to the site of infection.

Case # 2. A 6 year old child presented with 1 day of fever, diffuse maculopapular rash, and knee pain after returning from a 1 month trip to Puerto Rico a few days prior to admission secondary to chikungunya fever.

From: http://www.cdc.gov/chikungunya/images/maps/CHIK_Americas_Map-081214.jpg

1. Chikungunya ("that which bends up" in Tanzanian), was first described from an outbreak of fever in Tanzania in 1952.

2. It is characterized by fever that lasts for 3-5 days followed 2-5 days later by polyarthralgia (hands > wrists > ankles) that can sometimes be extremely debilitating. A diffuse maculopapular rash (which is pruritic in up to 50%) occurs in 40-75% of patients.  After the acute illness, up to 60% of patients can have persistent joint pains for up to 36 months.

3. The closest differential diagnosis is dengue fever as it is also transmitted by the Aedes mosquito vector. The main difference between dengue and chikungunya fever is that myalgia and polyarthralgia are virtually present in all chikungunya patients while they are uncommon findings in dengue patients. Thrombocytopenia is also more severe in dengue fever.

4. If the illness is suspected early (<5 days), obtaining plasma for viral PCR testing is the best method to diagnose chikungunya fever. Plasma viral-specific IgM and neutralizing antibodies are usually checked after 5 days of illness. Samples should be sent to the state laboratory or the CDC.

5. Outbreaks have traditionally been localized in Africa, Asia, and Europe but in December 2013, for the first time, chikungunya virus was found in the Americas. At present, there is an outbreak of chikungunya fever in the Caribbean. In July 2014, 2 patients from Florida who had not traveled outside of the US were diagnosed with chikungunya fever as reported by the CDC (read here).

Case # 3. A 21 year old woman from India develops fever, myalgia, diarrhea, severe leucopenia/thrombocytopenia, rhabdomyolysis, hepatitis, and multi-organ failure secondary to ciprofloxacin-resistant Salmonella enterica serotype Typhi infection (typhoid fever)

1. Tyhpoid fever can cause bone marrow suppression either by direct infiltration or induction of the macrophage activating system (hemophagocytic syndrome). Salmonella in the bone marrow can also lead to granuloma formation.

2. Alternative antibiotics used for the treatment of ciprofloxacin-resistant Salmonella include: ceftriaxone, azithromycin, or chloramphenicol. Other agents that may be active include imipenem and trimethoprim-sulfamethoxazole.

August 19, 2014 Grand Rounds

Case # 1. A 35/F presented with 4 month history of fever, diarrhea, vomiting, 30 pound weight loss, and granulomatous ileitis 

1. Several differential diagnoses were brought up including tuberculosis, histoplasmosis, Crohn's disease, sarcoidosis, and lymphoma. A useful article to review the different causes of granulomatous disease is linked to Case # 3 from June, 17, 2014.

2. It is hard to distinguish Crohn's disease from gastrointestinal tuberculosis especially in areas where the prevalence of both diseases is high. A positive anti-Saccharomyces cerevesiae (ASCA) antibody test is common in patients with Crohn's disease while a positive tuberculin skin test (TST) or interferon gamma release assay can be supportive of tuberculosis. Tissue culture remains the gold standard of diagnosing gastrointestinal tuberculosis.

3. Again, it was emphasized (similar to Case # 3 from June 17, 2014) that multiple tissue biopsies and cultures should be obtained to determine the cause of the granulomatous process. Empiric anti-tuberculous treatment may be warranted in some patients if the index of suspicion for tuberculosis is high.

Case # 2. A 7-week old infant presented with 1 day history of irritability, low grade fever, tachycardia, and localized neck cellulitis and adenitis secondary to group B Streptococcus (GBS)

From: http://www.giglig.com/wp-content/uploads/2011/09/Streptococcus.jpg

1. GBS cellulitis-adenitis syndrome is a rare (34 cases in the literature) but well-described late-onset GBS disease in neonates and infants. The median age of onset is 4.5 weeks. It usually presents as fever, increased irritability, and poor feeding followed by the appearance of lymphadenitis that is usually located in the submandibular region. In >90% of cases, GBS is isolated from the blood or from the lymph node.  

Case # 3. A 58/F presented with acute onset fever, nausea, vomiting, diarrhea, leukocytosis to 44,000, enterocolitis on CT scan, and septic shock several weeks after completing levofloxacin treatment for community acquired pneumonia; stool C. difficile toxin test is negative on two occasions

From: https://ndnr.com/wp-content/uploads/2012/01/10045000_m.jpg

1. The sensitivity of Clostridium difficile toxin enzyme immunoassay (EIA) is 63-94% depending on the the commercial test used (read here). The EIA we use for detecting Clostridium difficile toxin in our hospital is called TECHLAB assay. From the package insert, this test, compared to tissue culture cytotoxicity assay which is the gold standard in diagnosing Clostridium difficile, has a sensitivity of 92.2%, specificity of 100%, negative predictive value of 98.6%, and positive predictive value of 100% (read here).

2. The EIA can have as much as 10-20% false negative rate (read here). Thus, in some rare cases when this test is negative, it may be reasonable to continue treatment for Clostridium difficile. Although, in these cases, one should always look for other competing diagnoses such as ischemic bowel disease and other antibiotic-associated enterocolitis (e.g. Campylobacter, Salmonella).

August 12, 2014 Grand Rounds

Case # 1. A 19 year old African American man who presents with a recent history of proven HSV encephalitis treated with 21 days of intravenous acyclovir presented with recurrent neurological symptoms and worsening brain MRI findings secondary to recurrent versus refractory HSV.

From: http://posterng.netkey.at/esr/viewing/index.php?module=viewimage&task=&mediafile_id=508165&201302022314.gif

1. In most HSV encephalitis cases, 21 days of acyclovir may be enough. However, in cases where the initial infection is severe, like in this patient with extensive edema of the temporal lobe and serious neurological manifestations, treating for more than 21 days may be beneficial. We can learn from how our Pediatric Infectious Disease group here treat neonatal HSV encephalitis. On the 19th day of acyclovir treatment, a repeat lumbar puncture is performed and HSV PCR is rechecked from the CSF. If this comes back positive for HSV, treatment is extended for another 1-2 weeks.

2. Relapses of HSV encephalitis are usually seen in the pediatric age group, especially in those patients treated with only 10 days of acyclovir.

3. Interestingly, another differential diagnosis for a patient with relapsing symptoms after treatment of HSV encephalitis is anti-NMDA receptor encephalitis! Infection with HSV in the brain triggers the production of NMDA receptor antibodies that are responsible for this syndrome. Read more here. This is not the case here as our patient has a positive CSF HSV PCR on readmission. 

4. Anti-NMDA receptor encephalitis is an autoimmune disorder usually seen among young women with an ovarian teratoma that is characterized by prominent psychiatric manifestations, autonomic instability, mutism, memory deficits, and dyskinesias (read here for a good review). Every infectious disease physician should know this diagnosis as its prevalence now surpasses that of viral encephalitis in the California Encephalitis Project cohort (read here). Anti-NMDA encephalitis is treated with steroids.

4. Recurrent HSV encephalitis merits a work-up for immunodeficiency. Toll-like receptor 3 (TLR3) deficiency and NK cell deficiency predispose patients to developing recurrent HSV encephalitis.

Case # 2. A 20 month old child presented with a 3-day history of an ulcerating lesion in the nose secondary to ecthyma gangrenosum as a result of Pseudomonas aeruginosa infection.

From: http://www.langetextbooks.com/0071774343/gallery/035_ch18.jpg

1. Ecthyma gangrenosum is not exclusive to Pseudomonas. Staphylococcus aureus, other gram negative bacteria, and fungi are also known to cause it. 

2. Ecthyma gangrenosusm starts out as a painless macule. It then rapidly develops induration and becomes pustular (sometimes bullous). Later on, it ulcerates and becomes gangrenous (with a central black eschar). The final appearance (as shown in the picture) is a lesion with a necrotic center surrounded by a usually raised red or violaceous border. The evolution from a macule to a necrotic ulcer typically takes 12-18 hours!

Case # 3. A 68 year old man with pure red cell aplasia of undetermined cause, history of recent alemtuzumab treatment, who presented with fever, chest pain, and pulmonary infiltrates associated with a pleural effusion secondary to Actinomyces naeslundii.

1. Alemtuzumab is an anti-CD52 monoclonal antibody used in many refractory lymphoproliferative diseases and autoimmune conditions. It causes a profound depletion of T cells that lasts for many months. Its use has been associated with development of a variety of opportunistic (especially CMV, PML, adenovirus, toxoplasmosis) and non-opportunistic infections (e.g. bloodstream infections). Read more here.

2. We often think of actinomycosis when the infection is said to spread beyond tissue planes. Well, if caught early, like in this case, we can just sometimes appreciate localized disease (in this case, empyema without chest wall extension).

3. Remember that even if Actinomyces is an anaerobic bacteria, it is resistant to metronidazole.

August 5, 2014 Grand Rounds

Case 1. 52 year old woman with SLE who presents with chronic progressive headache, diplopia, blurring of vision, numbness of her toes, and constitutional symptoms secondary to histoplasmosis.

 From: https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEixsT5aJ5G8uBhS4qVZHCyssDojsaqfcvKBj0wnpJ7fwG6WzN6wuFxqrfG1dsTS3zD9rcbGz4wD4dA2aDZEdJcTPMeto4ifEHU-xZyT5-cLe86qSxO1dmSUfnBan6AIxh93JQ35ebEtkkw/s1600/fungal+distribution.png

1. Urine Histoplasma antigen cross-reacts with blastomycosis, paracoccidioidomycosis, penicilliosis, coccidioidomycosis, and African histoplasmosis. Only blastomycosis is endemic in Missouri. Treatment of histoplasmosis is very similar to that of blastomycosis.

2. Blastomyces antibody testing, which is usually done by an immunodiffusion assay, has low sensitivity but relatively good specificity. It cross-reacts with histoplasmosis, however. 

3. Distinguishing blastomycosis and histoplasmosis may be difficult and sometimes rely on isolation of the actual fungus from a tissue specimen. Clinically, they can present similarly as well. However, there are some important distinctions.

• Pulmonary findings are identical (from solitary to multiple lesions, from nodular to cavitary infiltrates).
• Skin findings may help differentiate the two. Histoplasma can give rise to almost any skin findings. Erythema nodosum and erythema multiforme are common. Blastomyces, on the other hand, presents usually with a short list of skin manifestations. This includes pyogranulomatous lesions with pseudoepitheliomatous hyperplasia (sometimes misdiagnosed as skin cancer). It can also present with ulcerating or verrucous lesions or cold abscesses. 
• Brain abscess and bone and joint infection are also more prominent clinical manifestations of blastomycosis.
• To confuse you further, African histoplasmosis (Histoplasma capsulatum var duboisii) presents exactly like blastomycosis (in terms of bulky skin lesions and prominent bone and joint involvement).

Case 2. A 17 year old girl who presents with acute exudative tonsillopharyngitis, fever, and pneumonia secondary to Lemierre's syndrome caused by Fusobacterium necrophorum.

From: http://iam.uic.edu/wp-content/uploads/2012/03/Lemierre-Syndrome-2.jpg

1. Sore throat followed by pneumonia, especially where chest imaging suggests possible septic emolization, should raise suspicion for Lemierre's syndrome. In this situation, get a Doppler ultrasound of the neck to look for internal jugular vein thrombosis.

2. Anticoagulation in cases of Lemierre's syndrome is still a controversial topic. At least two case series of Lemierre's syndrome showed no difference in outcome among patients who received anticoagulation compared to those who did not.

Case 3. A 73 year old man with history of recurrent and metastatic cholangiocarcinoma presents with multiple metastatic versus septic embolization of the liver, spleen, and kidneys as well as a new 3+ aortic regurgitation associated with an aortic valve vegetation.

From: http://classconnection.s3.amazonaws.com/695/flashcards/739695/jpg/me1316628051717.jpg

1. Nonbacterial thrombotic endocarditis (NBTE) (formerly known as marantic endocarditis) are most commonly seen in patients with advanced malignancy (usually lung and gastrointestinal cancer). It can also be seen in patients with rheumatologic conditions. 

2. In a case series of cancer patients with NBTE, one-third had mild to moderate valvular regurgitation (look here).

3. It is very difficult to distinguish NBTE from culture-negative endocarditis. Obtaining a specimen of the valve and the vegetation, which is an impractical approach especially for cancer patients who are not good candidates for surgery, may sometimes be the only way to differentiate the two.